Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,560.00    60.00 (1.09%)
Bid:
5,560.00
Ask:
5,570.00
Spread: 10.00 (0.18%)
Market Cap: £2.98b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Directorate Change

5 Mar 2018 07:00

RNS Number : 6120G
Cranswick PLC
05 March 2018
 

5 March 2018

Cranswick plc("Cranswick" or "the Company" or "the Group")

Directorate changes

Cranswick plc announces the appointment, with effect from 1 April 2018, of Pam Powell and Tim Smith as independent non-executive directors of the Company.

Pam Powell

Pam has a long and successful international career in strategy, marketing and innovation in fast moving consumer goods, including latterly, food and beverages. Pam spent nine years at SABMiller plc, holding the position of Group Director of Strategy and Innovation, and prior to this, worked at Coty Europe in France, Unilever plc in London, and Lever Brothers in New York.

Pam is currently a non-executive director of Premier Foods plc and A.G. Barr plc. No other information on Pam is required to be disclosed pursuant to Listing Rule 9.6.13R.

Tim Smith

Tim has extensive experience of the UK food sector having worked in food manufacturing, government regulation and supermarket retail during his career.

Most recently, Tim worked at Tesco plc between 2012 and 2017 as its Group Quality Director where he was responsible for product development, responsible sourcing, quality and technical matters. Prior to joining Tesco, Tim was the Chief Executive of the Food Standards Agency between 2008 and 2012 during which time he led a strategic review of the agency and also developed strong relationships with regulatory organisations and government in the UK and the rest of the world. Before joining the Food Standards Agency, Tim led a number of food manufacturing businesses including Express Dairies plc and Arla Foods plc where Tim became Chief Executive in 2005 with responsibility for delivery of the group's strategic plan including a £180million investment programme. Tim also sits on the board of a number of food industry and charitable bodies.

No other information on Tim is required to be disclosed pursuant to Listing Rule 9.6.13R.

 

Martin Davey, Chairman of Cranswick plc, commented:

"I am delighted that Pam and Tim will be joining our board. They bring significant additional expertise and sector experience which the Group will benefit from as it continues to move forward and develop."

 

 

For further information, please contact:

Enquiries:

Cranswick plc

01482 372 000

Mark Bottomley, Finance Director

 

 

 

Powerscourt

020 7250 1446

Nick Dibden / Lisa Kavanagh

cranswick@powerscourt-group.com

 

Notes:

1. Cranswick's activities are focused within the UK and include the processing and supply of fresh pork, sausage, bacon, cooked meats, premium fresh and cooked poultry, charcuterie and pastry products. Products are primarily supplied into the UK food retail, food service and food manufacturing sectors. Results for the year to 31 March 2017 showed revenue from continuing operations of £1,245m and profit before tax on the same basis of £77.5m.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUSUBRWAAORAR
Date   Source Headline
3rd Feb 20227:00 amRNSThird quarter trading statement
1st Feb 202210:25 amRNSTotal Voting Rights
31st Jan 20227:00 amRNSAcquisition of dry pet food producer
27th Jan 20229:03 amRNSListing of Ordinary Shares
19th Jan 20223:31 pmRNSHolding(s) in Company
4th Jan 202211:32 amRNSTotal Voting Rights
24th Dec 202110:55 amRNSCranswick Scrip Dividend Scheme
3rd Dec 20219:49 amRNSTotal Voting Rights
29th Nov 20213:24 pmRNSHolding(s) in Company
25th Nov 20214:50 pmRNSDirector/PDMR Shareholding
23rd Nov 20215:35 pmRNSDirector/PDMR Shareholding
23rd Nov 20217:00 amRNSInterim Results
4th Nov 20218:43 amRNSHolding(s) in Company
1st Oct 202112:45 pmRNSBlock listing Interim Review
1st Oct 202112:44 pmRNSBlock listing Interim Review
1st Oct 202112:40 pmRNSTotal Voting Rights
30th Sep 20215:16 pmRNSHolding(s) in Company
27th Sep 20213:55 pmRNSDirector/PDMR Shareholding
27th Sep 20213:54 pmRNSDirector/PDMR Shareholding
3rd Sep 202112:18 pmRNSUpdate re Listing of Ordinary Shares
2nd Sep 20218:42 amRNSListing pursuant to Scrip Shares and TVR
1st Sep 20214:34 pmRNSTotal Voting Rights
12th Aug 20215:55 pmRNSHolding(s) in Company
11th Aug 20212:25 pmRNSDirector/PDMR Shareholding
11th Aug 20212:24 pmRNSDirector/PDMR Shareholding
11th Aug 20212:24 pmRNSDirector/PDMR Shareholding
11th Aug 20212:20 pmRNSDirector/PDMR Shareholding
11th Aug 20212:20 pmRNSDirector/PDMR Shareholding
3rd Aug 202111:53 amRNSDirector/PDMR Shareholding
3rd Aug 202111:50 amRNSTotal Voting Rights
29th Jul 20212:48 pmRNSCRANSWICK SCRIP DIVIDEND SCHEME
26th Jul 20212:58 pmRNSDirector/PDMR Shareholding
26th Jul 20212:57 pmRNSDirector/PDMR Shareholding
26th Jul 20212:50 pmRNSAppointment of Chairman and Poll Result -2021 AGM
26th Jul 20212:48 pmRNSTransaction in Own Shares
26th Jul 20217:00 amRNSFirst quarter trading statement
13th Jul 20211:45 pmRNSANNUAL GENERAL MEETING 2021 – UPDATE
12th Jul 20213:46 pmRNSHolding(s) in Company
1st Jul 20218:59 amRNSTotal Voting Rights
24th Jun 20219:00 amRNSHolding(s) in Company
18th Jun 20212:24 pmRNSHolding(s) in Company
1st Jun 20212:35 pmRNSDirector/PDMR Shareholding
1st Jun 20212:25 pmRNSTotal Voting Rights
1st Jun 20212:24 pmRNSDirector/PDMR Shareholding
21st May 202111:00 amRNSDirector/PDMR Shareholding
21st May 202110:59 amRNSDirector/PDMR Shareholding
21st May 202110:59 amRNSDirector/PDMR Shareholding
21st May 202110:59 amRNSDirector/PDMR Shareholding
20th May 202112:08 pmRNSDirector/PDMR Shareholding
20th May 202112:06 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.